Developer docs
API playgroundTry for free, no card

Search company profiles

BIO INX

Full company profile

uuid000c3q4

Namestring
BIO INX
Legal namestring
BIO INX BV
Websiteurl
bioinx.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

BIO INX BV is a Belgian biomaterials company headquartered in Zwijnaarde (Ghent), founded in 2022 as a spin-off from Ghent University and the Vrije Universiteit Brussel (VUB). It develops and commercializes ready-to-use bioinks, bioink precursors and biomaterial resins used in 3D bioprinting, with a particular focus on light-based, high-resolution printing modalities — including multiphoton lithography (2PP), volumetric (tomographic) printing, digital light processing/stereolithography (DLP/SLA), and extrusion-based printing. Its portfolio includes flagship products such as GEL-MA INX X-Pure (the first GMP-like gelatin-based bioink, developed with Rousselot), READYGEL INX and READYPCL INX for volumetric bioprinting with Readily3D systems, DEGRES INX (a biodegradable, shape-memory resin enabling 4D bioprinting), BIORES INX for DLP, and a deep line of HYDROBIO INX, HYDROTECH INX, and DEGRAD INX variants for multiphoton lithography on Nanoscribe and Upnano systems. The company holds the granted CURASOL patent for UV-crosslinkable solid inks and operates under an inbound license to the foundational GelMA patent, with multiple products carrying ISO 10993-5 biocompatibility certification.

The firm's commercial model is B2B, with revenue generated from one-time unit sales of bioink kits and bioink precursors. Distribution is multi-channel: direct through the bioinx.com e-commerce platform, through major laboratory suppliers (Carl ROTH globally), and through OEM-aligned channel partners that bundle BIO INX materials with their printers (Nanoscribe, Upnano, Felix Printers, Regemat 3D, Yamato Scientific in Japan, MP Strumenti in Italy). Go-to-market is characterized as 'plug & print' — standardized, pre-optimized formulations intended to minimize end-user optimization effort and enable reproducible outcomes across printing technologies. Pricing is quote-based and not publicly disclosed.

BIO INX sells into academic and research institutions, pharmaceutical/biotech drug-discovery and animal-free testing programs, and clinical/regenerative-medicine developers. Distribution today covers Europe (HQ Belgium, plus Italy and Germany via partners), Japan, and DACH, with a global reach claim supported by Carl ROTH. The company employs 1–10 people and was founded by CEO Jasper Van Hoorick, CSO Aysu Arslan, COO Coralie Gréant, and Prof. Sandra Van Vlierberghe (co-author of the original GelMA patent). Awards include 3DNatives Startup of the Year 2023, UNIZO Starter van het Jaar 2023, and Top Biomaterials Development Company in Europe 2026.

Short descriptiontext

BIO INX is a Belgian spin-off from Ghent University and VUB that develops and commercializes standardized, ready-to-use bioinks and biomaterial resins for 3D bioprinting — spanning multiphoton lithography, volumetric, DLP, and extrusion printing — sold B2B to academic, pharmaceutical, and regenerative-medicine customers globally via e-commerce and distribution partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersZwijnaarde, Belgium
HQ citystring
Zwijnaarde
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
3D bioprinting materials, bioink development, tissue engineering biomaterials, biocompatible hydrogels, photopolymerizable bioinks
Industry2 codes
PRIMARYHLAAAGAC
3D Bioprinting & Biofabrication
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYIMANAAAG
Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends)
NAICS code2 codes
  • Plastics Material and Resin Manufacturing325211
  • Custom Compounding of Purchased Resins325991
SIC code2 codes
  • Plastic Materials, Synth Resins & Nonvulcan Elastomers2821
  • Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)2820
Product category
3D Bioprinting Materials
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Bioink and Biomaterial Sales
TypeOne Time License
Description

BIO INX generates revenue primarily through the sale of ready-to-use bioinks, bioink precursors, and proprietary biomaterial formulations for 3D bioprinting. Products are sold directly via their e-commerce platform and through distribution partnerships globally.

bioinx.com
2Distribution Revenue
TypeOne Time License
Description

Products distributed through partner networks including Nanoscribe, Upnano, Felix Printers, Regemat 3D, Yamato Scientific, MP Strumenti, and Carl ROTH generate revenue through wholesale/distribution arrangements.

bioinx.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Pricing details1 tier
1Product catalog through webshop with distribution partner access
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products sold individually; specific pricing available upon quote request. Distributed globally through multiple channel partners.

bioinx.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

BIO INX develops and commercializes ready-to-use bioinks, bioink precursors, and proprietary biomaterial formulations for 3D bioprinting across multiple printing modalities including multiphoton lithography (2PP), volumetric printing, DLP/stereolithography, and extrusion-based printing. The company offers a comprehensive portfolio of standardized, 'plug & print' materials spanning gelatin methacryloyl (GelMA)-based bioinks, biodegradable polyester resins, shape-memory polymers, and GMP-like formulations to support researchers and clinicians from bench to bedside.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • UV-induced crosslinking in solid state occurs 5 times faster compared to molten state inks
+2 more records
Product overview1 text field

BIO INX is a pioneering developer of materials for 3D bioprinting, offering a comprehensive portfolio of ready-to-use bioinks and bio ink precursors for multiple printing technologies. The product portfolio includes: GEL-MA INX X-Pure (first GMP-like gelatin-based bioink for clinical translation), READYGEL INX (Gel-MA based ink for volumetric printing with Readily3D systems), DEGRES INX (shape-memory biodegradable resin for 4D bioprinting), BIORES INX (gelatin-based DLP resin), and READYPCL INX (polyester-based resin for volumetric printing). For multiphoton lithography, BIO INX offers HYDROBIO INX (cell-encapsulating bioinks in U200, N400, X400 formulations), Hydrotech INX N200 (macroscale 2PP hydrogel), HYDROTECH INX N100 (robust synthetic hydrogel), DEGRAD INX N100/U100 (biodegradable polyester resins). Additionally, BIO INX distributes X-Pure gelatin precursors in partnership with Rousselot. The company focuses on standardization and reproducibility ('plug & print' philosophy) across extrusion-based, DLP, and light-based high-resolution printing technologies.

Product and service11 records
1GEL-MA INX X-Pure
CategoryReady-to-use bioinks
Description

First GMP-like ready-to-use gelatin-based bioink based on Rousselot's X-Pure gelatin, enabling printing constructs in the presence of living cells. Represents a significant step toward clinical translation of 3D bioprinting for tissue engineering and regenerative medicine applications.

2READYGEL INX
CategoryReady-to-use bioinks
Description

Gel-MA based ink specifically tailored for volumetric printing. Delivered sterile and ready-to-use, with preoptimized processing parameters for high reproducibility in Readily3D's Tomolite volumetric bioprinting system. Low light dose (<600 mJ/cm²) makes it cell- and organoid-friendly.

3DEGRES INX
CategoryReady-to-use bioinks
Description

First biodegradable and biocompatible polyester-based resin with shape memory properties for light-based (bio)printing. Can be deformed into a temporary shape after 3D printing and returns to its original printed shape when heated to body temperature (37°C), enabling 4D bioprinting. ISO 10993-5 certified biocompatible.

4BIORES INX
CategoryReady-to-use bioinks
Description

Groundbreaking gelatin methacrylamide (GelMA)-based resin for digital light processing (DLP) bioprinting. Combines exceptional biocompatibility, ease of use, and cross-platform compatibility, eliminating challenges such as heating and water evaporation during printing.

5READYPCL INX
CategoryReady-to-use bioinks
Description

World's first commercially available polyester-based resin for volumetric bioprinting, developed in collaboration with Readily3D for use with their Tomolite volumetric printing system. Available in 10ml and 20ml kit sizes.

6HYDROBIO INX
CategoryReady-to-use bioinks
Description

Gelatin-based bioink enabling live cell encapsulation in multiphoton lithography/high-resolution Two-Photon Polymerization (2PP). Available in multiple formulations (U200, N400, X400) optimized for different printer systems. Water-soluble hydrogel mimicking natural cellular environment and biodegradable.

7Hydrotech INX N200
CategoryReady-to-use bioinks
Description

World's first hydrogel resin for Two-Photon Polymerization (2PP) enabling macroscale 3D printing (up to a few millimeters) using Nanoscribe's patented Dip-in Laser Lithography (DiLL) technology. ISO-10993-5 certified biocompatible, bio-inert, liquid, and water-soluble.

8HYDROTECH INX N100
CategoryReady-to-use bioinks
Description

Robust synthetic hydrogel processed in solid state using BIO INX's patented Curasol technology. After immersion in aqueous environment, forms a very robust hydrogel. Optimized for Nanoscribe systems.

9DEGRAD INX N100
CategoryReady-to-use bioinks
Description

First biodegradable polyester-based synthetic Two-Photon Polymerization resin. Combines biocompatibility with flexibility and easy processing thanks to Curasol technology, resulting in high feature resolutions (<500 nm).

10DEGRAD INX U100
CategoryReady-to-use bioinks
Description

World's first polyester-based biodegradable resin for two-photon polymerization (2PP), used in the pioneering high-resolution 3D bioprinter developed at TU Wien that achieved the fastest high-resolution 3D printer ever reported.

11X-Pure Gelatin Bioink Precursors
CategoryBioink precursors
Description

Research and technical grade X-Pure gelatin biomaterials distributed by BIO INX in collaboration with Rousselot. Functionally equivalent to GMP-grade gelatins, helping reduce development variability and facilitate transition to clinical applications.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-03
Description

Official distributor of BIO INX products in Italy. This collaboration marks an important step in BIO INX's continued European expansion and strengthens its presence in one of Europe's most dynamic biofabrication markets.

Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-11-05
Description

Official distributor of BIO INX products in Japan. This collaboration marks an important milestone in BIO INX's global expansion strategy and strengthens its presence in one of the world's most technologically advanced markets.

Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-11-26
Description

Distribution partnership to expand access to 3D bioprinting solutions. Carl ROTH now offers BIO INX's entire portfolio, marking Carl ROTH's first foray into 3D bioprinting space. Partnership streamlines logistics and accelerates bioprinting advancements for researchers worldwide through Carl ROTH's established distribution network.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-18
Description

Collaboration to achieve unparalleled standardization and reproducibility in extrusion-based bioprinting. Puredyne contributes cutting-edge extrusion printhead technology; BIO INX provides reproducible bioinks. Partnership combines Puredyne's heated printhead module with BIO INX's Gel-MA INX inks for the Brinter One and Brinter Core bioprinting systems. Puredyne is a brand of ViscoTec Pumpen- u. Dosiertechnik GmbH based in Germany.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-18
Description

Partnership with BIO INX and Puredyne to set new standards in extrusion bioprinting. AM Technologies by Brinter brings advanced bioprinter manufacturing expertise with solutions including bioprinters designed for International Space Station. Integration of Puredyne's heated printhead into Brinter One and Brinter Core systems.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-05-22
Description

Strategic partnership to introduce new biomaterials for volumetric 3D bioprinting. First product is READYGEL INX, a state-of-the-art gel-MA based ink designed for high reproducibility and performance in tomographic printing. Readily3D develops Tomolite volumetric 3D printers. Partnership aligns with BIO INX's vision of bringing bioprinting technology to clinics.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-03-12
Description

Strategic collaboration on materials for 3D bioprinting. BIO INX distributes Rousselot's X-Pure gelatin biomaterials and introduced X-Pure version of GEL-MA INX, the first GMP-like gelatin-based bioink. Collaboration builds on 25+ year relationship; original GelMA was developed using Rousselot gelatin at Ghent University. Rousselot is a global leader in gelatin- and collagen-based solutions.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-10-19
Description

Distribution agreement via launch of portfolio of biocompatible materials for high-resolution biofabrication. Products include HYDROBIO INX (gelatin-based bioink kit), HYDROTECH INX (synthetic hydrogel), and DEGRAD INX (biodegradable polyester-based resin). Nanoscribe is the world leader in two-photon polymerization equipment and part of the BICO Group.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-09-10
Description

Distribution agreement for tailored high-quality bioinks for the FELIX BIOprinter. Based on 10 years of experience in additive manufacturing, FELIXprinters developed a novel high-performance bioprinter.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-08-26
Description

Launch of X Hydrobio INX U200, the first multiphoton lithography bioink for Upnano's NanoOne Bio-printer. Materials enable 3D printing of structures with living cells at both meso- and microscale. Upnano is a Vienna-based high-tech company, spin-out of TU Wien, focusing on high-resolution 3D-printing systems based on 2-photon polymerization.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partnership for deposition-based printing bioinks. Regemat 3D is an innovator in bioprinter manufacturing.

12Smart BioMaterials Consortium (SBMC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership for InCart-3D project focused on developing enabling platform technology (combination of bioink and printing process) for bone and cartilage damage. Project funded by €240,000 Interreg CrossRoads Program. SBMC is based in Eindhoven, Netherlands.

bioinx.com
13HU3DINKS Consortium
Strategic tierCoreTypeStrategic or Co-development Partner
Description

IraSME research project developing human tissue-based bioinks for multiple 3D bioprinting technologies. Consortium includes THT Biomaterials (Vienna, Austria), Morphomed (Vienna), UpNano (Vienna), and Ludwig Boltzmann Institute for Traumatology. Belgium partners funded by VLAIO; Austria partners by FFG. Project aims for animal-free testing using human-derived materials.

bioinx.com
14AstroCardia Project Consortium
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Belgian consortium developing artificial 'heart-on-a-chip' for space-based heart ageing research. Partners include Space Applications Services, SCK CEN, QbD Group, and Antleron. BIO INX contributes bioinks for 3D bioprinting miniature hearts for the International Space Station. Project leverages accelerated ageing processes in space for cardiac research.

bioinx.com
15Belgian Ceramic Research Center (CRIBC)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

RAPIDOS project partner focused on developing bone-specific bioresins for DLP printing. Collaboration with CERAMATHS laboratory funded by Interreg Flanders-France-Wallonia Programme.

bioinx.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

RAPIDOS project partner alongside CRIBC and BIO INX for developing bone-specific bioresins for DLP printing.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Cellink is the market-leading bioink and 3D bioprinting consumables brand within BICO Group. It overlaps with BIO INX across nearly all bioprinting modalities (extrusion, DLP, photopolymerization) but focuses on a broader B2C and B2B catalog including bioprinters themselves.

TypeDirect peer
Description

Allevi (now part of 3D Systems) develops bioinks and extrusion-based bioprinters for tissue engineering. Directly comparable to BIO INX's deposition-based ink portfolio, with similar B2B academic and pharma customer base.

TypeDirect peer
Description

Organovo develops 3D bioprinted human tissue models for drug discovery and disease research. Comparable to BIO INX's pharmaceutical use case (3D tissue models for drug screening) but operates further downstream as a tissue model provider.

4Aspect Biosystems
TypeDirect peer
Description

Aspect Biosystems develops bioink materials and microfluidic 3D bioprinting platforms for therapeutic discovery. Overlaps with BIO INX in bioink development and pharma/biotech customer segments.

TypeDirect peer
Description

Swiss developer of bioprinters and associated bioink materials for tissue engineering and regenerative medicine. Comparable target market and product/market fit with BIO INX across extrusion and light-based modalities.

TypeOthers
Description

Global leader in gelatin and collagen-based solutions, and an active strategic partner of BIO INX (distributing X-Pure gelatin for the GEL-MA INX X-Pure product). Comparable as a biomaterial supplier in the life sciences space, but as an upstream/partner rather than direct competitor.

TypeDirect peer
Description

AMS Bio distributes life science research products including 3D cell culture and bioprinting materials (e.g., VitroGel, PeptiGel). Comparable to BIO INX in serving academic and pharma researchers with hydrogel/bioink reagents.

8SunP Biotech
TypeEmerging player
Description

Develops gelatin methacryloyl (GelMA) and other bioinks for bioprinting, and has been a notable academic spin-out like BIO INX. Overlaps in core GelMA-based bioink offering for academic and research customers.

TypeOthers
Description

Developer of Tomolite volumetric 3D bioprinters and co-development partner of BIO INX. Comparable as a bioprinting equipment supplier; sits at the equipment tier of the same value chain.

TypeOthers
Description

World leader in two-photon polymerization (2PP) hardware and strategic distribution partner of BIO INX. Comparable as a high-resolution 3D bioprinting equipment provider; in BIO INX's value chain rather than a competitor on materials.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BIO INX

3D Bioprinting Materialsbioinx.com

BIO INX is a Belgian spin-off from Ghent University and VUB that develops and commercializes standardized, ready-to-use bioinks and biomaterial resins for 3D bioprinting — spanning multiphoton lithography, volumetric, DLP, and extrusion printing — sold B2B to academic, pharmaceutical, and regenerative-medicine customers globally via e-commerce and distribution partners.

What BIO INX does

BIO INX BV is a Belgian biomaterials company headquartered in Zwijnaarde (Ghent), founded in 2022 as a spin-off from Ghent University and the Vrije Universiteit Brussel (VUB). It develops and commercializes ready-to-use bioinks, bioink precursors and biomaterial resins used in 3D bioprinting, with a particular focus on light-based, high-resolution printing modalities — including multiphoton lithography (2PP), volumetric (tomographic) printing, digital light processing/stereolithography (DLP/SLA), and extrusion-based printing. Its portfolio includes flagship products such as GEL-MA INX X-Pure (the first GMP-like gelatin-based bioink, developed with Rousselot), READYGEL INX and READYPCL INX for volumetric bioprinting with Readily3D systems, DEGRES INX (a biodegradable, shape-memory resin enabling 4D bioprinting), BIORES INX for DLP, and a deep line of HYDROBIO INX, HYDROTECH INX, and DEGRAD INX variants for multiphoton lithography on Nanoscribe and Upnano systems. The company holds the granted CURASOL patent for UV-crosslinkable solid inks and operates under an inbound license to the foundational GelMA patent, with multiple products carrying ISO 10993-5 biocompatibility certification.

The firm's commercial model is B2B, with revenue generated from one-time unit sales of bioink kits and bioink precursors. Distribution is multi-channel: direct through the bioinx.com e-commerce platform, through major laboratory suppliers (Carl ROTH globally), and through OEM-aligned channel partners that bundle BIO INX materials with their printers (Nanoscribe, Upnano, Felix Printers, Regemat 3D, Yamato Scientific in Japan, MP Strumenti in Italy). Go-to-market is characterized as 'plug & print' — standardized, pre-optimized formulations intended to minimize end-user optimization effort and enable reproducible outcomes across printing technologies. Pricing is quote-based and not publicly disclosed.

BIO INX sells into academic and research institutions, pharmaceutical/biotech drug-discovery and animal-free testing programs, and clinical/regenerative-medicine developers. Distribution today covers Europe (HQ Belgium, plus Italy and Germany via partners), Japan, and DACH, with a global reach claim supported by Carl ROTH. The company employs 1–10 people and was founded by CEO Jasper Van Hoorick, CSO Aysu Arslan, COO Coralie Gréant, and Prof. Sandra Van Vlierberghe (co-author of the original GelMA patent). Awards include 3DNatives Startup of the Year 2023, UNIZO Starter van het Jaar 2023, and Top Biomaterials Development Company in Europe 2026.

BIO INX firmographics

Firmographics
Name
BIO INX
Legal name
BIO INX BV
Website
https://bioinx.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
BIO INX is a Belgian spin-off from Ghent University and VUB that develops and commercializes standardized, ready-to-use bioinks and biomaterial resins for 3D bioprinting — spanning multiphoton lithography, volumetric, DLP, and extrusion printing — sold B2B to academic, pharmaceutical, and regenerative-medicine customers globally via e-commerce and distribution partners.
Ownership category
akta.pro rank

BIO INX industry classification

Industry
Product category
3D Bioprinting Materials
NAICS
Plastics Material and Resin Manufacturing (325211), Custom Compounding of Purchased Resins (325991)
SIC
Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821), Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) (2820)
akta.pro industry
PRIMARYHLAAAGAC
3D Bioprinting & Biofabrication
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYIMANAAAG
Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends)

Keywords

  • 3D bioprinting materials
  • Bioink development
  • Tissue engineering biomaterials
  • Biocompatible hydrogels
  • Photopolymerizable bioinks

Where BIO INX is headquartered

Location

Headquarters

HQ city
Zwijnaarde
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

BIO INX business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Bioink and Biomaterial Sales: BIO INX generates revenue primarily through the sale of ready-to-use bioinks, bioink precursors, and proprietary biomaterial formulations for 3D bioprinting. Products are sold directly via their e-commerce platform and through distribution partnerships globally.
  2. Distribution Revenue: Products distributed through partner networks including Nanoscribe, Upnano, Felix Printers, Regemat 3D, Yamato Scientific, MP Strumenti, and Carl ROTH generate revenue through wholesale/distribution arrangements.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goProduct catalog through webshop with distribution partner access

Go-to-market motion3 records

Distribution channels7 records

Marketing channels5 records

BIO INX product offering

Product offering

Core offering

BIO INX develops and commercializes ready-to-use bioinks, bioink precursors, and proprietary biomaterial formulations for 3D bioprinting across multiple printing modalities including multiphoton lithography (2PP), volumetric printing, DLP/stereolithography, and extrusion-based printing. The company offers a comprehensive portfolio of standardized, 'plug & print' materials spanning gelatin methacryloyl (GelMA)-based bioinks, biodegradable polyester resins, shape-memory polymers, and GMP-like formulations to support researchers and clinicians from bench to bedside.

Product overview

BIO INX is a pioneering developer of materials for 3D bioprinting, offering a comprehensive portfolio of ready-to-use bioinks and bio ink precursors for multiple printing technologies. The product portfolio includes: GEL-MA INX X-Pure (first GMP-like gelatin-based bioink for clinical translation), READYGEL INX (Gel-MA based ink for volumetric printing with Readily3D systems), DEGRES INX (shape-memory biodegradable resin for 4D bioprinting), BIORES INX (gelatin-based DLP resin), and READYPCL INX (polyester-based resin for volumetric printing). For multiphoton lithography, BIO INX offers HYDROBIO INX (cell-encapsulating bioinks in U200, N400, X400 formulations), Hydrotech INX N200 (macroscale 2PP hydrogel), HYDROTECH INX N100 (robust synthetic hydrogel), DEGRAD INX N100/U100 (biodegradable polyester resins). Additionally, BIO INX distributes X-Pure gelatin precursors in partnership with Rousselot. The company focuses on standardization and reproducibility ('plug & print' philosophy) across extrusion-based, DLP, and light-based high-resolution printing technologies.

Differentiator

Problem solved

Functional benefit

Products and services

  • GEL-MA INX X-Pure First GMP-like ready-to-use gelatin-based bioink based on Rousselot's X-Pure gelatin, enabling printing constructs in the presence of living cells. Represents a significant step toward clinical translation of 3D bioprinting for tissue engineering and regenerative medicine applications.
  • READYGEL INX Gel-MA based ink specifically tailored for volumetric printing. Delivered sterile and ready-to-use, with preoptimized processing parameters for high reproducibility in Readily3D's Tomolite volumetric bioprinting system. Low light dose (<600 mJ/cm²) makes it cell- and organoid-friendly.
  • DEGRES INX First biodegradable and biocompatible polyester-based resin with shape memory properties for light-based (bio)printing. Can be deformed into a temporary shape after 3D printing and returns to its original printed shape when heated to body temperature (37°C), enabling 4D bioprinting. ISO 10993-5 certified biocompatible.
  • BIORES INX Groundbreaking gelatin methacrylamide (GelMA)-based resin for digital light processing (DLP) bioprinting. Combines exceptional biocompatibility, ease of use, and cross-platform compatibility, eliminating challenges such as heating and water evaporation during printing.
  • READYPCL INX World's first commercially available polyester-based resin for volumetric bioprinting, developed in collaboration with Readily3D for use with their Tomolite volumetric printing system. Available in 10ml and 20ml kit sizes.
  • HYDROBIO INX Gelatin-based bioink enabling live cell encapsulation in multiphoton lithography/high-resolution Two-Photon Polymerization (2PP). Available in multiple formulations (U200, N400, X400) optimized for different printer systems. Water-soluble hydrogel mimicking natural cellular environment and biodegradable.
  • Hydrotech INX N200 World's first hydrogel resin for Two-Photon Polymerization (2PP) enabling macroscale 3D printing (up to a few millimeters) using Nanoscribe's patented Dip-in Laser Lithography (DiLL) technology. ISO-10993-5 certified biocompatible, bio-inert, liquid, and water-soluble.
  • HYDROTECH INX N100 Robust synthetic hydrogel processed in solid state using BIO INX's patented Curasol technology. After immersion in aqueous environment, forms a very robust hydrogel. Optimized for Nanoscribe systems.
  • DEGRAD INX N100 First biodegradable polyester-based synthetic Two-Photon Polymerization resin. Combines biocompatibility with flexibility and easy processing thanks to Curasol technology, resulting in high feature resolutions (<500 nm).
  • DEGRAD INX U100 World's first polyester-based biodegradable resin for two-photon polymerization (2PP), used in the pioneering high-resolution 3D bioprinter developed at TU Wien that achieved the fastest high-resolution 3D printer ever reported.
  • X-Pure Gelatin Bioink Precursors Research and technical grade X-Pure gelatin biomaterials distributed by BIO INX in collaboration with Rousselot. Functionally equivalent to GMP-grade gelatins, helping reduce development variability and facilitate transition to clinical applications.

Quantifiable outcome

  • UV-induced crosslinking in solid state occurs 5 times faster compared to molten state inks
  • +2 more outcomes

Companies that use BIO INX

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles4 records

BIO INX technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature8 records

BIO INX partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered major, core and minor.

  • MP StrumentimajorChannel Partner/ Reseller/ Distributor · 3 May 2026Official distributor of BIO INX products in Italy. This collaboration marks an important step in BIO INX's continued European expansion and strengthens its presence in one of Europe's most dynamic biofabrication markets.
  • Yamato ScientificmajorChannel Partner/ Reseller/ Distributor · 5 November 2025Official distributor of BIO INX products in Japan. This collaboration marks an important milestone in BIO INX's global expansion strategy and strengthens its presence in one of the world's most technologically advanced markets.
  • Carl ROTHmajorChannel Partner/ Reseller/ Distributor · 26 November 2024Distribution partnership to expand access to 3D bioprinting solutions. Carl ROTH now offers BIO INX's entire portfolio, marking Carl ROTH's first foray into 3D bioprinting space. Partnership streamlines logistics and accelerates bioprinting advancements for researchers worldwide through Carl ROTH's established distribution network.
  • PuredynecoreStrategic or Co-development Partner · 18 November 2024Collaboration to achieve unparalleled standardization and reproducibility in extrusion-based bioprinting. Puredyne contributes cutting-edge extrusion printhead technology; BIO INX provides reproducible bioinks. Partnership combines Puredyne's heated printhead module with BIO INX's Gel-MA INX inks for the Brinter One and Brinter Core bioprinting systems. Puredyne is a brand of ViscoTec Pumpen- u. Dosiertechnik GmbH based in Germany.
  • AM Technologies by BrintercoreStrategic or Co-development Partner · 18 November 2024Partnership with BIO INX and Puredyne to set new standards in extrusion bioprinting. AM Technologies by Brinter brings advanced bioprinter manufacturing expertise with solutions including bioprinters designed for International Space Station. Integration of Puredyne's heated printhead into Brinter One and Brinter Core systems.
  • Readily3DcoreStrategic or Co-development Partner · 22 May 2024Strategic partnership to introduce new biomaterials for volumetric 3D bioprinting. First product is READYGEL INX, a state-of-the-art gel-MA based ink designed for high reproducibility and performance in tomographic printing. Readily3D develops Tomolite volumetric 3D printers. Partnership aligns with BIO INX's vision of bringing bioprinting technology to clinics.
  • RousselotcoreStrategic or Co-development Partner · 12 March 2024Strategic collaboration on materials for 3D bioprinting. BIO INX distributes Rousselot's X-Pure gelatin biomaterials and introduced X-Pure version of GEL-MA INX, the first GMP-like gelatin-based bioink. Collaboration builds on 25+ year relationship; original GelMA was developed using Rousselot gelatin at Ghent University. Rousselot is a global leader in gelatin- and collagen-based solutions.
  • NanoscribecoreChannel Partner/ Reseller/ Distributor · 19 October 2021Distribution agreement via launch of portfolio of biocompatible materials for high-resolution biofabrication. Products include HYDROBIO INX (gelatin-based bioink kit), HYDROTECH INX (synthetic hydrogel), and DEGRAD INX (biodegradable polyester-based resin). Nanoscribe is the world leader in two-photon polymerization equipment and part of the BICO Group.
  • Felix PrintersminorChannel Partner/ Reseller/ Distributor · 10 September 2021Distribution agreement for tailored high-quality bioinks for the FELIX BIOprinter. Based on 10 years of experience in additive manufacturing, FELIXprinters developed a novel high-performance bioprinter.
  • UpnanocoreChannel Partner/ Reseller/ Distributor · 26 August 2021Launch of X Hydrobio INX U200, the first multiphoton lithography bioink for Upnano's NanoOne Bio-printer. Materials enable 3D printing of structures with living cells at both meso- and microscale. Upnano is a Vienna-based high-tech company, spin-out of TU Wien, focusing on high-resolution 3D-printing systems based on 2-photon polymerization.
  • Regemat 3DminorChannel Partner/ Reseller/ DistributorDistribution partnership for deposition-based printing bioinks. Regemat 3D is an innovator in bioprinter manufacturing.
  • Smart BioMaterials Consortium (SBMC)coreStrategic or Co-development PartnerPartnership for InCart-3D project focused on developing enabling platform technology (combination of bioink and printing process) for bone and cartilage damage. Project funded by €240,000 Interreg CrossRoads Program. SBMC is based in Eindhoven, Netherlands.
  • HU3DINKS ConsortiumcoreStrategic or Co-development PartnerIraSME research project developing human tissue-based bioinks for multiple 3D bioprinting technologies. Consortium includes THT Biomaterials (Vienna, Austria), Morphomed (Vienna), UpNano (Vienna), and Ludwig Boltzmann Institute for Traumatology. Belgium partners funded by VLAIO; Austria partners by FFG. Project aims for animal-free testing using human-derived materials.
  • AstroCardia Project ConsortiumcoreStrategic or Co-development PartnerBelgian consortium developing artificial 'heart-on-a-chip' for space-based heart ageing research. Partners include Space Applications Services, SCK CEN, QbD Group, and Antleron. BIO INX contributes bioinks for 3D bioprinting miniature hearts for the International Space Station. Project leverages accelerated ageing processes in space for cardiac research.
  • Belgian Ceramic Research Center (CRIBC)minorStrategic or Co-development PartnerRAPIDOS project partner focused on developing bone-specific bioresins for DLP printing. Collaboration with CERAMATHS laboratory funded by Interreg Flanders-France-Wallonia Programme.
  • CERAMATHS LaboratoryminorStrategic or Co-development PartnerRAPIDOS project partner alongside CRIBC and BIO INX for developing bone-specific bioresins for DLP printing.

Scale indicators2 records

Recent moves8 records

Expansion highlights6 records

BIO INX competitors and assessment

Company assessment

Broad incumbents

  • Cellink (BICO Group): Cellink is the market-leading bioink and 3D bioprinting consumables brand within BICO Group. It overlaps with BIO INX across nearly all bioprinting modalities (extrusion, DLP, photopolymerization) but focuses on a broader B2C and B2B catalog including bioprinters themselves.

Direct peers

  • Allevi (3D Systems): Allevi (now part of 3D Systems) develops bioinks and extrusion-based bioprinters for tissue engineering. Directly comparable to BIO INX's deposition-based ink portfolio, with similar B2B academic and pharma customer base.
  • Organovo: Organovo develops 3D bioprinted human tissue models for drug discovery and disease research. Comparable to BIO INX's pharmaceutical use case (3D tissue models for drug screening) but operates further downstream as a tissue model provider.
  • Aspect Biosystems: Aspect Biosystems develops bioink materials and microfluidic 3D bioprinting platforms for therapeutic discovery. Overlaps with BIO INX in bioink development and pharma/biotech customer segments.
  • RegenHU: Swiss developer of bioprinters and associated bioink materials for tissue engineering and regenerative medicine. Comparable target market and product/market fit with BIO INX across extrusion and light-based modalities.
  • AMSBIO: AMS Bio distributes life science research products including 3D cell culture and bioprinting materials (e.g., VitroGel, PeptiGel). Comparable to BIO INX in serving academic and pharma researchers with hydrogel/bioink reagents.

Others

  • Rousselot ( Darling Ingredients): Global leader in gelatin and collagen-based solutions, and an active strategic partner of BIO INX (distributing X-Pure gelatin for the GEL-MA INX X-Pure product). Comparable as a biomaterial supplier in the life sciences space, but as an upstream/partner rather than direct competitor.
  • Readily3D: Developer of Tomolite volumetric 3D bioprinters and co-development partner of BIO INX. Comparable as a bioprinting equipment supplier; sits at the equipment tier of the same value chain.
  • Nanoscribe (BICO Group): World leader in two-photon polymerization (2PP) hardware and strategic distribution partner of BIO INX. Comparable as a high-resolution 3D bioprinting equipment provider; in BIO INX's value chain rather than a competitor on materials.

Emerging players

  • SunP Biotech: Develops gelatin methacryloyl (GelMA) and other bioinks for bioprinting, and has been a notable academic spin-out like BIO INX. Overlaps in core GelMA-based bioink offering for academic and research customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

BIO INX social profiles

Digital presence

BIO INX compliance and trust

Trust signal

Compliance2 records

BIO INX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BIO INX leadership team

Management profile

Number of profiles

Profiles6 records

BIO INX funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BIO INX M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIO INX

What does BIO INX do?

BIO INX develops and commercializes ready-to-use bioinks, bioink precursors, and proprietary biomaterial formulations for 3D bioprinting across multiple printing modalities including multiphoton lithography (2PP), volumetric printing, DLP/stereolithography, and extrusion-based printing. The company offers a comprehensive portfolio of standardized, 'plug & print' materials spanning gelatin methacryloyl (GelMA)-based bioinks, biodegradable polyester resins, shape-memory polymers, and GMP-like formulations to support researchers and clinicians from bench to bedside.

Is BIO INX a public or private company?

BIO INX is a private company. It is classified as venture growth investor backed and is currently operating.

When was BIO INX founded?

BIO INX was founded in 2022. It employs 1 to 10 people.

Where is BIO INX based?

BIO INX is headquartered in Zwijnaarde, Belgium, in the Europe region.

How does BIO INX make money?

Two revenue lines are on record. Bioink and Biomaterial Sales are the primary driver. The others are distribution Revenue.

Who are BIO INX's main competitors?

Cellink (BICO Group) is listed as a broad incumbent. Direct peers are Allevi (3D Systems), Organovo, Aspect Biosystems, RegenHU and AMSBIO. Others are Rousselot ( Darling Ingredients), Readily3D and Nanoscribe (BICO Group). SunP Biotech is listed as an emerging player.

Does BIO INX have an API?

No public API is recorded for BIO INX.

What industry is BIO INX in?

BIO INX's product category is 3D Bioprinting Materials. Its primary akta.pro industry code is HLAAAGAC, 3D Bioprinting & Biofabrication, with a secondary code of IMANAAAG, Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends). Its NAICS code is 325211 and its SIC code is 2821.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MaddynessFundtruck 2026 : découvrez les trois startups qui défendront les couleurs de la Belgique en finaleThree Belgian startups—Trosort, Bio Inx, and Nemesis—advanced to the Fundtruck 2026 final in Paris on November 26. Trosort automates textile waste sorting with AI, Bio Inx develops bio-inks for 3D-printed tissues, and Nemesis turns cyber threat data into attack simulations. The final is the culmination of the 2026 edition.VoxelMattersBIO INX’s DEGRAD INX resin helps regenerate cartilage in rabbit kneesResearchers at TU Wien, led by Prof. Aleksandra Ovsianikov and using Belgian resin DEGRAD INX, printed 0.3 mm spherical scaffolds seeded with stem-cell-derived cartilage cells into rabbit knee defects. After twelve weeks, regenerated tissue reached about 91% of natural cartilage thickness and was assessed as nearly normal. The team says the micro-scaffold strategy, developed over a decade, is now the first to work in a living organism.EIN PresswireBiodegradable Scaffold Market Strategic Insights, Emerging Opportunities, Key Trends, and Competitive LandscapeThe biodegradable scaffold market is projected to grow from USD 520 million in 2026 to USD 1,165 million by 2033, a CAGR of 12.2%. Hydrogels lead product type with 43.60% share, 3D printing leads technology with 37.70%, and orthopedics holds 28.40% revenue share. North America dominates with 41.20% share, while Asia Pacific is expected to be a lucrative market.GlobeNewswireBiocompatible 3D Printing Materials Market Trends Analysis Report 2025-2030: Increasing Demand of Biocompatible 3D Printing Materials in Healthcare SettingsThe global biocompatible 3D printing materials market was valued at USD 664.7 million in 2024 and is projected to grow at a 14.6% CAGR to USD 1,480 million by 2030. Recent developments include BIO INX's DEGRES INX biodegradable resin and VBN Components' wear-resistant alloys for medical implants.3D ADEPT MEDIABIO INX launches a gelatin-based DLP resin for 3D bioprintingBIO INX has launched BIORES INX, a sterile gelatin methacrylamide-based resin for DLP bioprinting, developed at Ghent University and meeting ISO 10993-5 biocompatibility standards. The room-temperature liquid formulation avoids heated containers and water evaporation, and is compatible across four bioprinting platforms. It is the second bioresin in BIO INX's DLP portfolio.3dprintBIO INX Releases Gelatin DLP Resin for Bioprinting - 3DPrint.comBelgian firm BIO INX has released a new gelatin DLP resin for bioprinting, derived from gelatin methacrylamide developed by Ghent University. This biocompatible resin, which simplifies processing and conforms to ISO 10993-5 standards, is suitable for hard and soft tissue applications. The company's ongoing innovations and focus on high-performance materials demonstrate a strategic alignment with emerging bioprinting needs.BioinxBIO INX and Carl ROTH Partner to Expand Access to 3D Bioprinting SolutionsBIO INX and Carl ROTH announced a distribution agreement on 27 November 2024, making BIO INX's full portfolio of bioinks available through Carl ROTH's webshop. BIO INX, a Ghent University spin-out, said the deal streamlines logistics and sales channels, while Carl ROTH, with over 40,000 products, marks its first entry into 3D bioprinting.BioviaBIO INX and Rousselot Announce Collaboration on Materials for 3D BioprintingBIO INX, a 3D bioprinting material developer, announced a collaboration with Rousselot to distribute the company's research and technical grade X-Pure gelatin biomaterials and introduce a GMP-like gelatin-based bioink, GEL-MA INX. BIO INX CEO Jasper Van Hoorick said the partnership adds standardization and quality to move the technology toward clinical applications.BioinxBIO INX and Rousselot Announce Collaboration on Materials for 3D BioprintingBIO INX, a developer of 3D bioprinting materials, announced a strategic collaboration with Rousselot, a global leader in gelatin and collagen solutions, to distribute Rousselot's research and technical grade X-Pure gelatin biomaterials. The X-Pure range will be integrated into BIO INX's offerings and made available through its webshop, with Rousselot's materials described as functionally equivalent to GMP-grade gelatins.